ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.00%
US Dollar vs AUD
1.49165
0.00%
Bitcoin
67,117.58
0.26%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Quoin Pharmaceuticals Ltd (QNRX)

  7. Quoin Pharmaceuticals Ltd (QNRX) News

QNRX

Quoin Pharmaceuticals (QNRX)

Quoin Pharmaceuticals Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:QNRX
DateTimeSourceHeadlineSymbolCompany
11/05/202406:10Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QNRXQuoin Pharmaceuticals Ltd
09/05/202422:30GlobeNewswire Inc.Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2024 Financial ResultsNASDAQ:QNRXQuoin Pharmaceuticals Ltd
09/05/202406:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QNRXQuoin Pharmaceuticals Ltd
03/05/202406:10GlobeNewswire Inc.Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024NASDAQ:QNRXQuoin Pharmaceuticals Ltd
14/03/202407:05GlobeNewswire Inc.Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial ResultsNASDAQ:QNRXQuoin Pharmaceuticals Ltd
13/03/202422:03IH Market NewsMixed Futures Amidst Quiet Economic Schedule; Oil Prices ClimbNASDAQ:QNRXQuoin Pharmaceuticals Ltd
09/03/202408:06Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QNRXQuoin Pharmaceuticals Ltd
09/03/202408:04Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QNRXQuoin Pharmaceuticals Ltd
09/03/202408:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QNRXQuoin Pharmaceuticals Ltd
08/03/202408:05GlobeNewswire Inc.Quoin Pharmaceuticals Announces Fourth Quarter and 2023 Financial Results and Corporate Update Conference Call to be held on Thursday March 14th at 8:30 am ETNASDAQ:QNRXQuoin Pharmaceuticals Ltd
07/03/202409:07Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:QNRXQuoin Pharmaceuticals Ltd
07/03/202408:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QNRXQuoin Pharmaceuticals Ltd
06/03/202400:00GlobeNewswire Inc.Quoin Pharmaceuticals Announces Pricing of $6.5 Million Public OfferingNASDAQ:QNRXQuoin Pharmaceuticals Ltd
05/03/202409:27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QNRXQuoin Pharmaceuticals Ltd
05/03/202400:00GlobeNewswire Inc.Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical StudiesNASDAQ:QNRXQuoin Pharmaceuticals Ltd
27/02/202422:01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:QNRXQuoin Pharmaceuticals Ltd
15/02/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:QNRXQuoin Pharmaceuticals Ltd
14/02/202412:11Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:QNRXQuoin Pharmaceuticals Ltd
14/02/202408:50Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:QNRXQuoin Pharmaceuticals Ltd
14/02/202408:30Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:QNRXQuoin Pharmaceuticals Ltd
13/02/202409:12Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:QNRXQuoin Pharmaceuticals Ltd
09/02/202400:00GlobeNewswire Inc.Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Netherton Syndrome Combination ProductNASDAQ:QNRXQuoin Pharmaceuticals Ltd
31/01/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QNRXQuoin Pharmaceuticals Ltd
19/12/202309:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QNRXQuoin Pharmaceuticals Ltd
19/12/202309:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QNRXQuoin Pharmaceuticals Ltd
14/12/202300:30GlobeNewswire Inc.Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton SyndromeNASDAQ:QNRXQuoin Pharmaceuticals Ltd
10/11/202309:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:QNRXQuoin Pharmaceuticals Ltd
10/11/202309:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QNRXQuoin Pharmaceuticals Ltd
10/11/202309:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QNRXQuoin Pharmaceuticals Ltd
09/11/202309:46GlobeNewswire Inc.Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2023 Financial ResultsNASDAQ:QNRXQuoin Pharmaceuticals Ltd
 Showing the most relevant articles for your search:NASDAQ:QNRX

Your Recent History

COIN
SKRTTUSD
Sekuritance
BIT
F15713
Vontobel Financial Produ...
USOTC
CVMCA
Sila Realty (PK)
EU
FGA
Figeac Aero
BIT
P1WYV1
NLBNPIT1WYV1 20240920 200
BOV
CEBR3R
CEB ON
BIT
FV112L
Vontobel
BIT
UB87PC
Unicredit Bank
AMEX
ICOW
Pacer Developed Markets ...
ASX
FXLKOE
TSXV
RES
Auric Resources
AMEX
XBOC
Innovator US Equity Acce...
UNSW3
OMETH
MANTRA DAO
LSE
BPFI
Blue Planet Gw&inc I.T.5
AMEX
DSE
Merrill LY Str Ixd
LATK
DBETETH
Decent.bet
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved